BACKGROUND: Among individuals with ischemic heart disease, young women with an acute myocardial infarction (AMI) represent an extreme phenotype associated with an excess mortality risk. Although women younger than 55 years of age account for less than 5% of hospitalized AMI events, almost 16 000 deaths are reported annually in this group, making heart disease a leading killer of young women. Despite a higher risk of mortality compared with similarly aged men, young women have been the subject of few studies. METHODS AND RESULTS: Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients (VIRGO) is a large, observational study of the presentation, treatment, and outcomes of young women and men with AMI. VIRGO will enroll 2000 women, 18 to 55 years of age, with AMI and a comparison cohort of 1000 men with AMI from more than 100 participating hospitals. The aims of the study are to determine sex differences in the distribution and prognostic importance of biological, demographic, clinical, and psychosocial risk factors; to determine whether there are sex differences in the quality of care received by young AMI patients; and to determine how these factors contribute to sex differences in outcomes (including mortality, hospitalization, and health status). Blood serum and DNA for consenting participants will be stored for future studies. CONCLUSIONS: VIRGO will seek to identify novel and prognostic factors that contribute to outcomes in this young AMI population. Results from the study will be used to develop clinically useful risk-stratification models for young AMI patients, explain sex differences in outcomes, and identify targets for intervention.
BACKGROUND: Among individuals with ischemic heart disease, young women with an acute myocardial infarction (AMI) represent an extreme phenotype associated with an excess mortality risk. Although women younger than 55 years of age account for less than 5% of hospitalized AMI events, almost 16 000 deaths are reported annually in this group, making heart disease a leading killer of young women. Despite a higher risk of mortality compared with similarly aged men, young women have been the subject of few studies. METHODS AND RESULTS: Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients (VIRGO) is a large, observational study of the presentation, treatment, and outcomes of young women and men with AMI. VIRGO will enroll 2000 women, 18 to 55 years of age, with AMI and a comparison cohort of 1000 men with AMI from more than 100 participating hospitals. The aims of the study are to determine sex differences in the distribution and prognostic importance of biological, demographic, clinical, and psychosocial risk factors; to determine whether there are sex differences in the quality of care received by young AMI patients; and to determine how these factors contribute to sex differences in outcomes (including mortality, hospitalization, and health status). Blood serum and DNA for consenting participants will be stored for future studies. CONCLUSIONS: VIRGO will seek to identify novel and prognostic factors that contribute to outcomes in this young AMI population. Results from the study will be used to develop clinically useful risk-stratification models for young AMI patients, explain sex differences in outcomes, and identify targets for intervention.
Authors: R M Steingart; M Packer; P Hamm; M E Coglianese; B Gersh; E M Geltman; J Sollano; S Katz; L Moyé; L L Basta Journal: N Engl J Med Date: 1991-07-25 Impact factor: 91.245
Authors: John A Spertus; Eric Peterson; John S Rumsfeld; Philip G Jones; Carole Decker; Harlan Krumholz Journal: Am Heart J Date: 2006-03 Impact factor: 4.749
Authors: Aakriti Gupta; Philip Chui; Shengfan Zhou; John A Spertus; Mary Geda; Nancy Lorenze; Ike Lee; Gail D' Onofrio; Judith H Lichtman; Karen P Alexander; Harlan M Krumholz; Jeptha P Curtis Journal: Am J Cardiol Date: 2015-04-06 Impact factor: 2.778
Authors: Rachel P Dreyer; Xiao Xu; Weiwei Zhang; Xue Du; Kelly M Strait; Maggie Bierlein; Emily M Bucholz; Mary Geda; James Fox; Gail D'Onofrio; Judith H Lichtman; Héctor Bueno; John A Spertus; Harlan M Krumholz Journal: Circ Cardiovasc Qual Outcomes Date: 2016-02
Authors: Erica C Leifheit-Limson; Gail D'Onofrio; Mitra Daneshvar; Mary Geda; Héctor Bueno; John A Spertus; Harlan M Krumholz; Judith H Lichtman Journal: J Am Coll Cardiol Date: 2015-11-03 Impact factor: 24.094
Authors: Xiao Xu; Haikun Bao; Kelly M Strait; Donald E Edmondson; Karina W Davidson; John F Beltrame; Héctor Bueno; Haiqun Lin; Rachel P Dreyer; John E Brush; John A Spertus; Judith H Lichtman; Gail DʼOnofrio; Harlan M Krumholz Journal: Psychosom Med Date: 2017-01 Impact factor: 4.312
Authors: Yuan Lu; Shengfan Zhou; Rachel P Dreyer; Michael Caulfield; Erica S Spatz; Mary Geda; Nancy P Lorenze; Peter Herbert; Gail D'Onofrio; Elizabeth A Jackson; Judith H Lichtman; Héctor Bueno; John A Spertus; Harlan M Krumholz Journal: Am Heart J Date: 2016-10-03 Impact factor: 4.749
Authors: Emily M Bucholz; Kelly M Strait; Rachel P Dreyer; Stacy T Lindau; Gail D'Onofrio; Mary Geda; Erica S Spatz; John F Beltrame; Judith H Lichtman; Nancy P Lorenze; Hector Bueno; Harlan M Krumholz Journal: Eur Heart J Acute Cardiovasc Care Date: 2016-08-02
Authors: Amit V Khera; Mark Chaffin; Seyedeh M Zekavat; Ryan L Collins; Carolina Roselli; Pradeep Natarajan; Judith H Lichtman; Gail D'Onofrio; Jennifer Mattera; Rachel Dreyer; John A Spertus; Kent D Taylor; Bruce M Psaty; Stephen S Rich; Wendy Post; Namrata Gupta; Stacey Gabriel; Eric Lander; Yii-Der Ida Chen; Michael E Talkowski; Jerome I Rotter; Harlan M Krumholz; Sekar Kathiresan Journal: Circulation Date: 2019-03-26 Impact factor: 29.690
Authors: Stacy Tessler Lindau; Emily Abramsohn; Hector Bueno; Gail D'Onofrio; Judith H Lichtman; Nancy P Lorenze; Rupa Mehta Sanghani; Erica S Spatz; John A Spertus; Kelly M Strait; Kristen Wroblewski; Shengfan Zhou; Harlan M Krumholz Journal: JAMA Cardiol Date: 2016-10-01 Impact factor: 14.676